Literature DB >> 16019473

A role for niches in hematopoietic cell development.

Beate Heissig1, Yuichi Ohki, Yayoi Sato, Shahin Rafii, Zena Werb, Koichi Hattori.   

Abstract

Stem cells reside in a physical niche, a particular microenvironment. The organization of cellular niches has been shown to play a key role in regulating normal stem cell differentiation, maintenance and regeneration. Hematopoietic stem cells (HSC) emerge at distinct allocation territories during ontogenesis, notably the aorto-gonadal region, the fetal liver. Adult HSC expand and differentiate exclusively in the bone marrow (BM). They can be mobilized into the blood stream. This implies that stem cells are not autonomous units of development; rather, tissue specific niches control their destiny. Interaction of HSCs with their stem cell niches is critical for adult hematopoiesis in the BM. A niche is composed of stromal cells, which either through direct cell-to-cell contact or via release of soluble factors maintain the typical features of stem cells, mainly stem cell quiescence, maintenance or expansion. HSCs are keeping the balance of the quiescence and the self-renewal in the stem cell niche, and are maintaining long-term hematopoiesis.Therefore, an understanding of cellular and chemical architecture of the stem cell niche is vital in understanding stem cell behavior. This review summarizes the recent developments in our understanding of the stem cell niche with particular focus on the HSC niche.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019473     DOI: 10.1080/10245330500067249

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  24 in total

1.  Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds.

Authors:  Evgenios A Neofytou; Edwin Chang; Bhagat Patlola; Lydia-Marie Joubert; Jayakumar Rajadas; Sanjiv S Gambhir; Zhen Cheng; Robert C Robbins; Ramin E Beygui
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

Review 2.  Mechanistic insights into the regulation of the spermatogonial stem cell niche.

Authors:  Rex A Hess; Paul S Cooke; Marie-Claude Hofmann; Kenneth M Murphy
Journal:  Cell Cycle       Date:  2006-06-01       Impact factor: 4.534

Review 3.  Potential for access to embryonic-like cells from human umbilical cord blood.

Authors:  C P McGuckin; N Forraz
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

4.  Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors.

Authors:  Edmond J Yunis; Joaquin Zúñiga; Prasad S Koka; Zaheed Husain; Viviana Romero; Joel N H Stern; Masha Fridkis-Hareli
Journal:  J Stem Cells       Date:  2006

5.  Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect.

Authors:  Michelle B Bowie; Kristen D McKnight; David G Kent; Lindsay McCaffrey; Pamela A Hoodless; Connie J Eaves
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

6.  Biology of umbilical cord blood progenitors in bone marrow niches.

Authors:  Mo A Dao; Michael H Creer; Jan A Nolta; Catherine M Verfaillie
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

7.  Role of the autonomic nervous system in rat liver regeneration.

Authors:  Cunshuan Xu; Xinsheng Zhang; Gaiping Wang; Cuifang Chang; Lianxing Zhang; Qiuyan Cheng; Ailing Lu
Journal:  Cell Mol Neurobiol       Date:  2011-01-25       Impact factor: 5.046

Review 8.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

9.  FoxP3+ regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells.

Authors:  Jee H Lee; Chuanwu Wang; Chang H Kim
Journal:  J Immunol       Date:  2009-11-15       Impact factor: 5.422

Review 10.  Bone marrow microenvironment and the identification of new targets for myeloma therapy.

Authors:  K Podar; D Chauhan; K C Anderson
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.